BSPED2018

07 November 2018

08:00-19:00Registration
08:50-09:00CME Day: Session 1
Chair(s):Anitha Kumaran (Southampton) & Renuka Dias (Birmingham)
The Studio
09:00CME1.1Techniques to maximise childhood and adult height
Martin Savage (London, UK)
09:30CME1.2Hypogonadotrophic hypogonadism - challenges in diagnosis and management
Liz Crowne (Bristol)
10:00-10:30CME Day: Oral Communications 1
Chair(s):Anitha Kumaran (Southampton) & Renuka Dias (Birmingham)
The Studio
10:00OC1.1Differentiating between SIADH and NSIAD in an infant presenting with hyponatraemia
Xanthippi Tseretopoulou (Leeds)
10:15OC1.2The complications of a goitre secondary to iodine deficiency
Elspeth Ferguson (Sheffield, UK)
10:30-11:00Tea & Coffee
Mezzanine
11:00-12:00CME Day: Session 2
Chair(s):Anitha Kumaran (Southampton) & Renuka Dias (Birmingham)
The Studio
11:00CME2.1Management of Obesity- what works ?
Nikki Davis (University Hospitals Southampton NHS Foundation Trust, Southampton, United Kingdom)
11:30CMW2.2Management of growth and body composition in Prader Willi syndrome
Shankar Kanumakala (Brighton)
12:00-12:30CME Day: Oral Communications 2
Chair(s):Anitha Kumaran (Southampton) & Renuka Dias (Birmingham)
The Studio
12:00OC2.1An Audit of Hypoglycemia screens in Paediatric and Neonatal Patients in Two District General Hospitals
Georgina Cameron (London)
12:15OC2.2The relationship of baseline, incremental and peak cortisol following a Short Synacthen Test – single-centre analysis of three years’ data
Apoorva Aji (Sheffield)
12:40-13:30Lunch
Mezzanine
13:30-14:30CME Day: Session 3
Chair(s):Anitha Kumaran (Southampton) & Suet Ching Chen (Glasgow)
The Studio
13:30CME3.1Approach to a child with recurrent fractures
Paul Arundel (Sheffield Children’s NHS Foundation Trust, Sheffield, UK)
14:00CME3.2Assessment and management of Tall stature
Jeremy Kirk (Birmingham, UK)
14:30-15:00CME Day: Oral Communications 3
Chair(s):Anitha Kumaran (Southampton) & Suet Ching Chen (Glasgow)
The Studio
14:30OC3.1Serial overnight growth hormone profiling in diagnosing growth hormone excess in McCune Albright Syndrome.
Nadia Amin (Leeds Teaching Hospital, Leeds, UK)
14:45OC3.2Haemolytic Uraemic Syndrome (HUS) – a rare cause of diabetes
Alghanay (Bridgend)
15:00-15:30Tea & Coffee
Mezzanine
15:30-16:15CME Day: Session 4
Chair(s):Anitha Kumaran (Southampton) & Suet Ching Chen (Glasgow)
The Studio
15:30CME4.1Structured pathway for management of High HbA1c
15:50CME4.2Role of youth worker, family support and social worker in supporting diabetes management
Melanie Kershaw (Birmingham)
16:15-16:30CME Officer's Update & Conclusion
The Studio
16:40-17:40Sponsored Symposium

08 November 2018

07:45-08:45Sponsored Symposium
08:00-19:00Registration
08:45-09:00Endocrine Main Meeting: Welcome from Convenors
The Studio
08:45Welcome from Convenors
Timothy Barrett (University of Birmingham, Birmingham, UK)
09:00-10:30Endocrine Main Meeting: Oral Communications 4
Chair(s):Mehul Dattani (London) & Helen Storr (London)
The Studio
09:10OC4.1Hydrocortisone granules in capsules for opening: phase 3 trial in children with adrenal insufficiency and long-term safety data
Alexander Lewis (Diurnal Ltd, Cardiff, UK)
09:20OC4.2Gene expression signatures in children with growth hormone deficiency (GHD) and Turner syndrome (TS) predict response to growth hormone
Adam Stevens (Manchester, United Kingdom)
09:30OC4.3Recommendations for management of paediatric phaeochromocytoma/paraganglioma (PCC/PGL):On behalf of the UK Paediatric PCC/PGL Guideline Development Group.
Prateek Yadev (London)
09:40OC4.4Identification and characterisation of a small-molecule ACTH receptor/Melanocortin-2-receptor antagonist
Li Chan (Queen Mary University of London , London, UK)
09:50OC4.5Delayed or Absent? - Use of Next Generation Sequencing Diagnostic Tools in a UK Puberty Cohort
Sasha Howard (Queen Mary University of London and Barts Health NHS Trust, London, UK)
10:00OC4.6Implementation of a novel non-invasive test for monitoring control in individuals with congenital adrenal hyperplasia
Irina A Bacila (Sheffield, UK)
10:10OC4.7Clinical Outcomes of Focal Congenital Hyperinsulinism - A UK Perspective
Antonia Dastamani (London, UK)
10:20OC4.8Prolactinoma in Childhood and Adolescence – outcomes relating to the size of tumour
Ved Arya (London)
09:00-10:30Diabetes Professionals Day: Session 1
Chair(s):Lesley Drummond (Birmingham)
The Suites
09:00S1.1Diasend Project
John Pemberton (Birmingham, UK)
09:30S1.2Social media and diabetes management - does it work?
Libby Dowling (London)
10:00S1.3Optimising Transition in Young Adults with Diabetes - the importance of hope?
09:00-09:45Endocrine Main Meeting - Nurses' AGM
Chair(s):Stephanie Kerr (Southampton) & Kate Davies (London)
09:45-10:30PENS Presentation Session
Chair(s):Stephanie Kerr (Southampton) & Kate Davies (London)
09:45PENS1.1Polycystic Kidney Disease with Hyperinsulinemic hypoglycaemia
Kate Morgan (London)
10:05PENS1.2PENS BSPED Prize: The Implementation of a Nurse Led Virtual Thyroid Clinic
Christine Desmond (Reading)
10:30-11:00Tea & Coffee
Mezzanine
11:00-11:30Diabetes Professionals' Day: Oral Communications 6
Chair(s):Ruth Krone (Birmingham) & Heather Stirling (Coventry)
The Suites
11:00OC6.1A Retrospective Regional Analysis of Outcomes during Transition of Young People with Type 1 Diabetes
Melanie Kershaw (Birmingham)
11:10OC6.2Perceptions of diabetes education: a questionnaire-based survey of 117 patients and families.
Allison Low (Sheffield)
11:20OC6.3Has the reduction in maintenance fluid rates following introduction of 2015 BSPED-recommended diabetic ketoacidosis guidelines impacted on complication rates?
Amish Chinoy (Manchester, United Kingdom)
11:00-12:30Symposium 1
Chair(s):Jeremy Kirk (Birmingham)
DSD/Adrenals
The Studio
11:00SY1.1Diagnostic approach to expanding aetiologies of DSD
Nils Krone (Sheffield, UK)
11:30SY1.2DSD surgery; the child’s best interests, and disclosure prior to consent
Robert Wheeler (Southampton)
12:00SY1.3Novel androgen pathways and their role in CAH
Wiebke Arlt (MRC Laboratory of Medical Sciences, London, UK)
11:30-12:30Diabetes Professionals Day: Session 2
Chair(s):Martha Ford-Adams (London)
Type II diabetes
The Suites
11:30S2.1Type 2 diabetes: insights from the adult clinic
Katharine Owen (Oxford)
12:00S2.2New Therapies in Type 2 diabetes
Billy White (London, United Kingdom)
12:30-13:30Lunch, exhibition & poster tours
Mezzanine
13:30-14:30Diabetes Professionals: Session 3
Chair(s):Chizo Agwu (Birmingham)
Technology in Diabetes
The Suites
13:30S3.1CGMS in children - current technologies and future prospects
Carlo Acerini (Cambridge)
14:00S3.2Practical Approach to Management of CGM and Flash Glucose (Libre) Systems for Children and Young People with T1DM
May Ng, OBE (Ormskirk, UK)
13:30-14:30Endocrine Main Meeting: Oral Communications 5
Chair(s):Ved Bhusan Arya (London) & Liz Crowne (Bristol)
The Studio
13:30OC5.1Growth outcomes in adolescents and adults with Silver-Russell syndrome and the effects of childhood growth hormone treatment.
Oluwakemi Lokulo-Sodipe (University of Southampton, Southampton, UK)
13:36OC5.2Screening for Co-Morbidities in Fibrous Dysplasia
Zilla Huma (London)
13:42OC5.3Can novel stem cell models help unpick the pathogenesis of the Triple A Syndrome?
Alexandra Costa (London)
13:48OC5.4Fourteen years experience of hydrocortisone pump therapy for cortisol replacement in adrenal insufficiency
Peter Hindmarsh (London)
13:54OC5.5New insights into the Low Dose Dexamethasone Suppression Test in paediatric Cushing’s Syndrome (CS)
Ingrid Wilkinson (London)
14:00OC5.6Successes and challenges around cohorted introduction of Burosumab in clinical treatment of X-Linked Hypophosphataemia (XLH)
Ian Tucker (Bristol)
14:06OC5.7A novel GHR pseudoexon mutation causing frameshift and severe postnatal growth failure
Emily Cottrell (London, UK)
14:12OC5.8Patients with short stature and GH/IGF-1 Insensitivity harbour Copy Number Variants causing a Silver-Russell-like Phenotype
Emily Cottrell (London, UK)
14:18OC5.9Diazoxide-induced pulmonary hypertension: UK multicentre retrospective study on the risk factors, monitoring approach andmanagement recommendations
Suet Ching Chen, MD (Glasgow, UK)
14:30-15:30Tea, coffee & poster tours
Mezzanine
15:30-16:30Symposium 2
Chair(s):Paul Arundel (Sheffield)
Bone health and disease
The Studio
15:30SY2.1Vitamin D - Beyond Bone
Martin Hewison (University of Birmingham, Birmingham, UK)
16:00SY2.2State of the Art Lecture: 20 years experience in Metabolic Bone
Nicholas Shaw (Birmingham)
15:30-16:30Diabetes Professionals Day: Session 4
Chair(s):Melanine Kershaw (Birmingham)
Debate
The Suites
15:30S4.1FOR: This house believes that Automation has primacy over Education in management of diabetes
Tabitha Randell (Nottingham, UK)
16:00S4.2AGAINST: This house believes that Automation has primacy over Education in management of diabetes
Fiona Campbell (Leeds Teaching Hospitals NHS Trust, Leeds, UK)
16:30-17:00Key Note Speaker: Session 5
Bone health and disease
The Studio
16:30S5Palaeopathology; diseases and excavations
Anthony Waldron (London)
16:30-17:00Key Note Speaker: Session 5
Bone health and disease
The Studio
16:30S5Palaeopathology; diseases and excavations
Anthony Waldron (London)
17:15-18:15BSPED AGM
The Studio

09 November 2018

08:00-19:00Registration
08:15-09:15Sponsored Symposium
09:30-11:00Symposium 3
Chair(s):Jo Blair (Liverpool)
Clinical Trials
The Studio
09:30SY3.1Lessons from TRIALNet
Polly Bingley (Bristol)
10:15SY3.2EXTOD - lessons for CYP
Parth Narendran (Birmingham, UK)
09:30-10:00Nurses' Day for Endocrine Professionals: Session 1
Chair(s):Stephanie Kerr (Southampton)
Gender Identity
The Suites
09:30ND1.1Gender Identity
Gary Butler (London)
10:00ND1.2Supporting Gender variant young people and their families
10:30-11:00Nurses Day for Endocrine Professionals: Oral Communications 8
Chair(s):Stephanie Kerr (Southampton) & Karis Reyes (Cambridge)
The Suites
10:30OC8.1Five year outcomes in a cohort with hypoglycaemia due to Congenital Hyperinsulinism
Laila Al-Hashmi (Manchester)
10:40OC8.2The effect of GnRHa treatment on bone density in young adolescents with gender dysphoria: findings from a large national cohort
Tobin Joseph (London)
10:50OC8.3Attitudes Toward Fertility and Reproductive Health Among Transgender Adolescents
Sandra Walton-Betancourth (London)
11:00-11:30Tea & Coffee
Mezzanine
11:30-13:00Diabetes Main Meeting: Oral Communications 7
Chair(s):Carlo Acerini (Cambridge) & Sophia Sakka (London)
The Studio
11:30OC7.1DeAPP (Diabetes Education APP): using flipped learning to deliver structured education in newly diagnosed type 1 diabetes patients
James Greening (Leicester)
11:40OC7.2Provision of Psychology Services for Children and Young People with Diabetes: A National Survey
Chizo Agwu (Birmingham)
11:50OC7.3The Determinants of Skeletal Morbidity And Fractures In Children With Type 1 Diabetes
Suet Ching Chen, MD (Glasgow, UK)
12:00OC7.4Parental language proficiency and glycaemic control in children with type 1 diabetes
Charlotte Jackson (London)
12:10OC7.5Diabetes control is worse in children and young people with type 1 diabetes requiring interpreter support
Jan Idkowiak (Birmingham, UK)
12:20OC7.6Type A Insulin Resistance Syndrome due to anINSRmutation Presenting with Diabetes Mellitus Evolving to Hyperandrogenism and PCOS
Arameh Aghababaie (London)
12:30OC7.7Knowledge and Confidence of Paediatric Middle Grade Doctors in Managing Out of Hours Diabetes Advice Calls
Elspeth Ferguson (Sheffield, UK)
12:40OC7.8Continuous Glucose Monitoring with Regular Clinical Review of Glycaemic Control in Children with Type 1 Diabetes Experiencing Frequent Unpredictable Hypoglycaemia.
Meera Parmar (Southampton)
11:30-13:00Nurses' Day for Endocrine Professionals: Session 2
Chair(s):Ian Tucker (Bristol) and Sally Tollerfield (London)
The Suites
11:30ND2.1Meet The Expert: Clincal differential diagnosis in short stature syndrome
Trevor Cole (Birmingham)
12:30ND2.2Patient experience: Growing Up with Russell Silver Syndrome
Jenny Child (Birmingham)
13:00-13:15Diabetes UK Update
The Studio
13:15-13:30BSPED 2018 Awards Session
The Studio
13:30-14:30Lunch, exhibition and poster tours
Mezzanine
14:30-16:00Symposium 4
Chair(s):Tim Barrett (Birmingham)
Rare Diabetes
The Studio
14:30SY4.1Diagnosis of Monogenic Diabetes
Sian Ellard (Exeter)
15:00SY4.2Management of CF-Related Diabetes
Catherine Peters (London, UK)
15:30SY4.3Beta Cell function and prospects for new treatments
David Hodson (University of Oxford, Oxford, UK)
14:30-16:00Symposium 5
Chair(s):James Law (Nottingham) & Renuka Dias (Birmingham)
The Suites
14:30SY5.1Pituitary Tumours
Niki Karavitaki (University of Birmingham, Birmingham, UK)
15:00SY5.2Thyrotoxicosis – what’s new and where are we going?
Tim Cheetham (Newcastle, UK)
15:30SY5.3State of the Art Lecture: NESGAS
Jeremy Kirk (Birmingham, UK)